Bak S, Tischer S, Dragon A, Ravens S, Pape L, Koenecke C, Oelke M, Blasczyk R, Maecker-Kolhoff B, Eiz-Vesper B. Selective Effects of mTOR Inhibitor Sirolimus on Naïve and CMV-Specific T Cells Extending Its [...] I, Ravens S, Goudeva L, Schultze-Florey C, Koenecke C, Blasczyk R, Koehl U, Heuft HG, Prinz I, Eiz-Vesper B, Maecker-Kolhoff B. Dissecting Epstein-Barr Virus-Specific T-Cell Responses After Allogeneic

refractoriness conditions. Börger AK, Eicke D, Wolf C, Gras C, Aufderbeck S, Schulze K, Engels L, Eiz-Vesper B, Schambach A, Guzman CA, Lachmann N, Moritz T, Martin U, Blasczyk R, Figueiredo C. Mol Med. 2016

tion. J Immunol 2014; 192(10): 4636-4647 Saragih H, Zilian E, Jaimes Y, Paine A, Figueiredo C, Eiz-Vesper B, Blasczyk R, Larmann J, Theilmeier G, Burg-Roderfeld M, Andrei-Selmer LC, Becker JU , Santoso

1097/TP.0000000000002675 Melk A, Babitsch B, Borchert-Morlins B, Claas F, Dipchand A I, Eifert S, Eiz-Vesper B, Epping J, Falk C S, Foster B, Geyer S, Gjertson D, Greer M, Haubitz M, Lau A, Maecker-Kolhoff

Zimmermann, David Hagin, Lilia Goudeva, Rainer Blasczyk, Armin Koch , Britta Maecker-Kolhoff, Britta Eiz-Vesper, Günter Höglinger, and Thomas Skripuletz. 2024. “Directly Isolated Allogeneic Virus-Specific T [...] M. Hoeper, Rainer Blasczyk, Heiner Wedemeyer, Elmar Jaeckel, Yang Li, Christine S. Falk, Britta Eiz-Vesper, and Richard Taubert. 2022. “Reduced Humoral but Stable Cellular SARS-CoV-2-Specific Immunity in [...] Gernot Beutel, Thomas Skripuletz, Rainer Blasczyk, Rita Beier, Britta Maecker-Kolhoff, and Britta Eiz-Vesper. 2022. “Antiviral T-Cell Frequencies in a Healthy Population: Reference Values for Evaluating Antiviral

Mangare C, Tischer-Zimmermann S, Riese SB, Dragon AC, Prinz I, Blasczyk R, Maecker-Kolhoff B, Eiz-Vesper B. Robust Identification of Suitable T-Cell Subsets for Personalized CMV-Specific T-Cell Immunotherapy [...] I, Ravens S, Goudeva L, Schultze-Florey C, Koenecke C, Blasczyk R, Koehl U, Heuft HG, Prinz I, Eiz-Vesper B, Maecker-Kolhoff B. Dissecting Epstein-Barr Virus-Specific T-Cell Responses After Allogeneic

glioblastoma without MGMT promoter hypermethylation. Neuro Oncol 2013; 15(10): 1405-1412 Wilsdorf N, Eiz-Vesper B, Henke-Gendo C, Diestelhorst J, Oschlies I, Hussein K , Pape L, Baumann U, Tönshoff B, Pohl M

2019; 145(2): 461-473 Danisch S, Slabik C, Cornelius A, Albanese M, Tagawa T, Chen YA, Krönke N , Eiz-Vesper B, Lienenklaus S, Bleich A, Theobald SJ, Schneider A, Ganser A, von Kaisenberg C, Zeidler R, H

J, Berger MM, Lobenwein C, Stankov MV, Cornberg M, David S, Behrens GMN, Witzke O, Blasczyk R, Eiz-Vesper B. COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral [...] Pink I, Hoeper MM, Blasczyk R, Winkler MS, Nehlmeier I, Kempf A, Hofmann-Winkler H, Hoffmann M, Eiz-Vesper B, Pöhlmann S, Behrens GMN. Humoral and cellular immune responses against SARS-CoV-2 variants and [...] RBD mutations. Cell Rep 2021 DOI: 10.1016/j.celrep.2021.109433 Kirchner T, Jaeckel E, Falk CS, Eiz-Vesper B, Taubert R. SARS-CoV-2-specific immunity in immunosuppressed COVID-19 convalescents with autoimmune

Wittke TC, Eigendorf J, Kerling A, Framke T, Melk A, Heuft HG, Blasczyk R, Maecker-Kolhoff B and Eiz-Vesper B (2020). High-intensity interval training in allogeneic adoptive T-cell immunotherapy - a big